1 Result: PepGen
FDA Notifies PepGen, LL Flooring Becomes Takeover Target, JOYY Beats Estimates: Key Updates and Market Movements
May 31st, 2023
PepGen Inc. (Nasdaq: PEPG), a biotechnology company specializing in genetic therapies, received a clinical hold notice from the U.S. Food and Drug Administration (FDA) for their Investigational New Drug Application (IND) related to a Phase 1 study of. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login